About us
IXICO has been working since 2004 to help advance therapies for neurological diseases
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of investigational therapies for neurological diseases through the application of medical image analysis and digital health data analytics, bringing safe and effective treatment to patients sooner.
Background
IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of investigational therapies for neurological diseases through the application of medical image analysis and digital health data analytics, bringing safe and effective treatment to patients sooner.
IXICO's timeline
- 2004: IXICO founded, a spin-out from London universities' ‘Information eXtraction from Images’ project
- 2006: Clinical trial platform launched
- 2007: First Phase 3 trial
- 2008: Web-based TrialTracker platform launched
- 2013: AIM listing
- 2014: Clinical decision support platform, Assessa, launched
- 2015: Post-marketing surveillance commercial collaboration
- 2017: Digital biomarkers commercial collaboration
READ MORE about Innovation at IXICO
Collaborations
Innovation is one of our core values, and collaboration is key to advancing treatments for neurological diseases. Working with partners in academia, business and charitable organisations, we help further the international scientific and regulatory agenda and provide access to our platform and advanced data analysis for innovative research.
Work with us
Careers at IXICO
IXICO is a fast-growing data analytics company based in London, UK, working with biopharmaceutical clients, academic partners and clinical research sites around the world.
Specializing in supporting clinical reasearch in neuroscience, we are a passionate and dedicated team of scientists, researchers, quality professionals, and business people, bringing together the essential skills required to innovate and develop and deliver cutting-edge technologies to support our clients' clinical research needs.